Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Potential mechanisms of Qili Qiangxin capsule to prevent pulmonary arterial hypertension based on network pharmacology analysis in a rat model

1 Apr 2022

Abstract excerpt

Background: Qili Qiangxin capsule (QQC), a traditional Chinese medicine, has recently been approved to treat pulmonary arterial hypertension (PAH). However, the multi-target mechanism through which QQC acts on PAH has not been clarified. The objective of this study was to explore the pharmacological processes of QQC for treating PAH. Methods: The rat model of PAH was established by administering monocrotaline...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiac Fibrosis and Remodeling
Share to Phosphodiesterase function and regulation
Share to Pulmonary Hypertension Research and Treatments

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35571420
DOI: 10.21037/atm-22-901

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Potential mechanisms of Qili Qiangxin capsule to prevent pulmonary arterial hypertension based on network pharmacology analysis in a rat modelPMID 35571420Read ↗

Mechanism of Protective Effect of Xuan-Bai-Cheng-Gi Decoction on LPS-Induced Acute Lung Injury Based on an Integrated Network Pharmacology and RNA-Sequencing ApproachSemantic proximity Read ↗

Analyzing the Molecular Mechanism of Eucalyptol, Limonene and Pinene Enteric Capsules (QIENUO) in the Treatment of Pulmonary cystic fibrosis with Network Pharmacology and Verifying Molecular DockingSemantic proximity Read ↗

A network pharmacology approach to explore the mechanism of HuangZhi YiShen Capsule for treatment of diabetic kidney diseaseSemantic proximity Read ↗

Exploring the Mechanism of Qidan Tongmai Tablets in Anti-Atherosclerosis Based on Network Pharmacology and Molecular DockingSemantic proximity Read ↗

Network pharmacology-based mechanistic investigation of Jinshui Huanxian formula acing on idiopathic pulmonary fibrosisSemantic proximity Read ↗

Investigation of Anti-Epithelial-Mesenchymal Transition and Anti-Inflammation effects of Qing Fei Hua Xian Decotion on Pulmonary Fibrosis via Network Pharmacology and Experimental VerificationSemantic proximity Read ↗

Network pharmacology, molecular docking, and experimental study for the mechanisms of Qishen Yiqi Pills against Cardiovascular DiseasesSemantic proximity Read ↗

Exploration of the molecular targets and mechanisms of suxiao xintong dropping pills for myocardial infarction by network pharmacology methodSemantic proximity Read ↗

Experimental evidence and network pharmacology-based analysis reveal the molecular mechanism of Tongxinluo capsule administered in coronary heart diseasesSemantic proximity Read ↗

Network Pharmacology Approach for the Mechanism of Traditional Chinese Medicine in AcneSemantic proximity Read ↗

A Network Pharmacology Approach to Explore the Potential Mechanisms of Huangqin-Baishao Herb Pair in Treatment of CancerSemantic proximity Read ↗

Molecular mechanism of the anti-lung cancer effect of Jin Ning Fang based on network pharmacology and experimental verificationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.